Leukemia, Lymphocytic, Chronic, B-CellLeukemia, LymphoidPrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionLeukemiaSurvival RateLeukemia, Myeloid, AcuteRemission, SpontaneousTreatment OutcomeCytarabineAsparaginaseAntineoplastic Combined Chemotherapy ProtocolsVincristinePrognosisSurvival AnalysisMethotrexateLeukemia, B-CellVidarabineRecurrenceDisease-Free SurvivalBone MarrowAntineoplastic AgentsLeukemic InfiltrationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell Survival6-MercaptopurineCyclophosphamideLeukemia, T-CellDaunorubicinPrecursor B-Cell Lymphoblastic Leukemia-LymphomaB-LymphocytesLeukemia, Biphenotypic, AcutePrednisoneTime FactorsRetrospective StudiesChlorambucilGene Expression Regulation, LeukemicLymphocytes, NullLeukemia, MyeloidLymphomaAcute DiseaseFollow-Up StudiesImmunoglobulin Heavy ChainsLeukemia-Lymphoma, Adult T-CellLeukemia, ExperimentalDrug Administration ScheduleKaryotypingCombined Modality TherapyAntibodies, MonoclonalBurkitt LymphomaDoxorubicinReceptors, Antigen, B-CellZAP-70 Protein-Tyrosine KinaseLeukemia, Hairy CellSalvage TherapyBone Marrow TransplantationPhiladelphia ChromosomeChromosome AberrationsDNA, NeoplasmRosette FormationAntibodies, Monoclonal, Murine-DerivedChromosomes, Human, 6-12 and XAnisocoriaKaplan-Meier EstimateCladribineNeoplasm StagingBlast CrisisLymphocytesTransplantation, HomologousTranslocation, GeneticTumor Cells, CulturedAntigens, NeoplasmCorneal PerforationDrug Therapy, CombinationT-LymphocytesDrug Resistance, NeoplasmLymphoma, Non-HodgkinFusion Proteins, bcr-ablLeukemia Virus, MurineClinical Trials as TopicMutationNeoplasm ProteinsDexamethasoneAntigens, CD5DNA NucleotidylexotransferaseApoptosisAntigens, CD38Risk FactorsSurvivalGraft SurvivalImmunophenotypingEtoposideFlow CytometryChromosomes, Human, Pair 14Immunoglobulin Variable RegionNeprilysinNeoplasm Recurrence, LocalBase SequenceCell Line, TumorDisease Progression